Step 1 topics → Musculoskeletal, Skin, and Connective Tissue → Malignant Hyperthermia

Malignant Hyperthermia

USMLE Step 1 trap: Fails to distinguish MH-triggering agents (volatile anesthetics, succinylcholine) from safe alternatives like propofol. Malignant hyperthermia is triggered specifically by volatile halogenated anesthetics (e.g., halothane, sevoflurane) and succinylcholine; propofol and non-depolarizing agents are safe.

Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle calcium regulation — and USMLE Step 1 tests it through intraoperative scenarios where you must identify the crisis, explain the mechanism, and name the antidote. Two reliable traps: students assume hyperthermia is the earliest sign because it's in the name, but hypercapnia and muscle rigidity come first; and students confuse dantrolene's mechanism with neuromuscular blockade, which is wrong both conceptually and clinically. A mutation in RYR1 causes uncontrolled Ca²⁺ release when exposed to volatile halogenated anesthetics or succinylcholine, driving a hypermetabolic crisis that kills if untreated.

The exam approaches this from three angles: mechanism (what RYR1 does, which agents trigger it), presentation (which sign appears first, and why), and management (dantrolene and why it works). The passage-based questions will often bury the trigger agent in the anesthesia setup and expect you to connect it to the pathophysiology. What makes this concept tricky is that students pattern-match 'anesthesia + crisis = MH' without distinguishing which anesthetics actually trigger it — and that distinction is exactly what the exam tests.

Two specific traps show up repeatedly on USMLE Step 1. First, students assume hyperthermia is the earliest sign because it's in the name — but hypercapnia and muscle rigidity come first. Second, students confuse dantrolene's mechanism with neuromuscular blockade, which is wrong both conceptually and clinically. Getting this concept right means understanding the Ca²⁺ physiology, not just memorizing a drug name.

From real student decks
43%have cards covering this topic
24%have mature cards

Common misconceptions

Common mistake
Wrong: Malignant hyperthermia is triggered by any general anesthetic including propofol.
Right: Malignant hyperthermia is triggered specifically by volatile halogenated anesthetics (e.g., halothane, sevoflurane) and succinylcholine; propofol and non-depolarizing agents are safe.
Propofol is an IV anesthetic that works via GABA-A receptors and has no interaction with the RYR1 receptor — it does not trigger MH and is actually a go-to safe agent for patients with known MH susceptibility. MH is triggered specifically by volatile halogenated anesthetics (halothane, sevoflurane, isoflurane, desflurane) and depolarizing agents like succinylcholine, all of which pathologically activate the mutant RYR1 receptor. When you see an MH question, check whether the anesthetic used is volatile or succinylcholine — if it's propofol alone, MH is off the table.
Common mistake
Wrong: Hyperthermia is the earliest sign of malignant hyperthermia.
Right: Hypercapnia (rising end-tidal CO2) and masseter muscle rigidity are the earliest signs of MH; hyperthermia is a later manifestation.
The name 'malignant hyperthermia' is misleading — temperature rises late in the crisis, after muscle hypermetabolism has already been running out of control for some time. The very first detectable signs are rising end-tidal CO2 (from increased CO2 production by hypermetabolic muscle) and masseter spasm or generalized rigidity (from uncontrolled Ca²⁺-driven muscle contraction). On the exam, if a stem asks what the anesthesiologist notices first, the answer is hypercapnia or muscle rigidity, not fever.
Common mistake
Wrong: Dantrolene treats MH by blocking the neuromuscular junction.
Right: Dantrolene treats MH by directly inhibiting the RYR1 ryanodine receptor in skeletal muscle sarcoplasmic reticulum, preventing pathologic calcium release.
Dantrolene acts entirely within the muscle cell — specifically at the RYR1 ryanodine receptor on the sarcoplasmic reticulum — to block the abnormal Ca²⁺ flood that drives the hypermetabolic crisis. It has nothing to do with the neuromuscular junction, acetylcholine, or motor nerve signaling. This distinction matters because NMJ blockers (like rocuronium or vecuronium) would be useless for MH, whereas dantrolene cuts off the problem at the source by directly dampening SR Ca²⁺ release.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the genetic basis of MH (autosomal dominant RYR1 mutation) and identify exactly which anesthetic agents trigger it — volatile halogenated agents (halothane, sevoflurane, isoflurane) and succinylcholine — versus safe agents like propofol and non-depolarizing neuromuscular blockers.
  2. Identify the earliest signs of MH in an intraoperative scenario: rising end-tidal CO2 (hypercapnia) and masseter muscle rigidity appear before hyperthermia, and the exam will present a timeline where you must pick the correct earliest marker.
  3. Explain dantrolene's mechanism at the molecular level — it directly inhibits the RYR1 ryanodine receptor in the sarcoplasmic reticulum of skeletal muscle, blocking pathologic Ca²⁺ release — and apply this to questions about why it works specifically for MH.

Can you avoid these mistakes?

A 24-year-old male is 20 minutes into an elective procedure under sevoflurane and succinylcholine when the anesthesiologist notices a rising end-tidal CO2 and jaw stiffness. Temperature is 37.4°C. What is the diagnosis, and what is the most appropriate immediate pharmacologic treatment?
A patient with a family history of malignant hyperthermia requires general anesthesia for an appendectomy. Which anesthetic regimen is safest: (A) halothane + rocuronium, (B) propofol + rocuronium, (C) sevoflurane + succinylcholine, or (D) isoflurane + vecuronium?
Dantrolene is administered to a patient in MH crisis. At which anatomical site and molecular target does dantrolene act to abort the crisis? Why would a non-depolarizing neuromuscular blocker fail to treat MH?
Rank the following MH signs in order of typical appearance: (A) hyperthermia, (B) hypercapnia, (C) masseter rigidity, (D) metabolic acidosis. Which would you expect to see first, and what drives that first sign at the cellular level?

Related topics

Bone Cells and Matrix Endochondral vs Membranous Ossification Fracture Healing Stages Compartment Syndrome

See how your Anki deck covers this topic.

Upload your deck for a free audit →